Axial - Foundation Medicine - by Joshua Elkington - Axial
First Comprehensive Next-gen Sequencing based Pan-Tumor Liquid Biopsy Test Approved - Onco'Zine
Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer | Nature Communications
Foundation Medicine and Chugai Announce Partnership with National Cancer Center for the Use of FoundationOne®Liquid in the Third Stage of SCRUM-Japan | Business Wire
Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France | Gustave Roussy
Foundation Medicine Acquires Lexent Bio, Inc., to Accelerate Liquid Biopsy Research and Development, and Advance Cancer Care
See more, do more
Foundation Medicine Announces Commercial Launch of Solid Tumor Liquid Biopsy
FoundationOne Liquid CDx
![Foundation Medicine review - 7 facts you should know [DECEMBER 2021]](https://nebula.org/blog/wp-content/uploads/2021/12/FoundationOne-CDx-testing-kit.png "Foundation Medicine review - 7 facts you should know [DECEMBER 2021]")
Foundation Medicine review - 7 facts you should know [DECEMBER 2021]
FoundationOne®CDx Technical Information Foundation Medicine, Inc. 150 Second Street, Cambridge, MA 02141 Phone: 617.418.2200 I
Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France | Gustave Roussy
FoundationOne Liquid
fmi-10k_20171231.htm
Comprehensive genomic profiling in oncology – from vision to reality | Latest news for Doctors, Nurses and Pharmacists | Pharmacy
Multi-gene Testing (NGS) for PIK3CA Mutations
Foundation Medicine Introduces FoundationOne®Liquid, the Latest Advance in the Company's Liquid Biopsy Test for Solid Tumors in Patients with Advanced Cancer | Technology Networks
Compare Our Tests | Foundation Medicine
Foundation Medicine Eyes Liquid Biopsy Expansion, DNA Methylation Adoption, with Lexent Bio Acquisition | Inside Precision Medicine
Foundation Medicine touts concordance ahead of FDA ruling on liquid biopsy test - MedCity News
Multi-gene Testing (NGS) for PIK3CA Mutations
Foundation Medicine launches liquid biopsy test - MedCity News
FoundationOne Liquid CDx | Foundation Medicine
Foundation Medicine receives FDA approval for pan-tumour biopsy test
